N-[2-(6-fluoro-1H-benzimidazol-2-yl)ethyl]-2-(3-piperidin-3-ylpyrazol-1-yl)acetamide;dihydrochloride
C19H25Cl2FN6O — CID 154905231
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(6-fluoro-1H-benzimidazol-2-yl)ethyl]-2-(3-piperidin-3-ylpyrazol-1-yl)acetamide;dihydrochloride
N-[2-(6-fluoro-1H-benzimidazol-2-yl)ethyl]-2-(3-piperidin-3-ylpyrazol-1-yl)acetamide;dihydrochloride (PubChem CID 154905231) has the molecular formula C19H25Cl2FN6O and a molecular weight of 443.35 g/mol. Its IUPAC name is N-[2-(6-fluoro-1H-benzimidazol-2-yl)ethyl]-2-(3-piperidin-3-ylpyrazol-1-yl)acetamide;dihydrochloride.
Molecular Properties
| Compound Name | N-[2-(6-fluoro-1H-benzimidazol-2-yl)ethyl]-2-(3-piperidin-3-ylpyrazol-1-yl)acetamide;dihydrochloride |
|---|---|
| PubChem CID | 154905231 |
| Molecular Formula | C19H25Cl2FN6O |
| Molecular Weight | 443.35 g/mol |
| Exact Mass | 442.15 |
| IUPAC Name | N-[2-(6-fluoro-1H-benzimidazol-2-yl)ethyl]-2-(3-piperidin-3-ylpyrazol-1-yl)acetamide;dihydrochloride |
| SMILES | Cl.Cl.O=C(Cn1ccc(C2CCCNC2)n1)NCCc1nc2ccc(F)cc2[nH]1 |
| InChI | InChI=1S/C19H23FN6O.2ClH/c20-14-3-4-16-17(10-14)24-18(23-16)5-8-22-19(27)12-26-9-6-15(25-26)13-2-1-7-21-11-13;;/h3-4,6,9-10,13,21H,1-2,5,7-8,11-12H2,(H,22,27)(H,23,24);2*1H |
| InChIKey | RJZVFDSEWLMGGC-UHFFFAOYSA-N |
| XLogP | 2.57 |
| TPSA | 87.63 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.35 |
| LogP ≤ 5 | 2.57 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154905231 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.